NASA Looking For Cost Effective Methods for Fulfilling Their Mars Invasion Dream

NASA Looking For Cost Effective Methods for Fulfilling Their Mars Invasion Dream

It has been revealed in a recent report that the NASA has completely dropped the idea for their ambitious Mars missions. They have definitely received a, major setback after the budget proposals from the Obama government were out recently.

This included cutting back on the funds for NASA’s Mars mission. This had to be done because the economic conditions of the entire world are currently staggering and it is essential that a judicious monetary management scheme is put to use.

The NASA has however not given up ad they shall be looking for cheaper options to get their mission to Mars underway by the year2018. They are hurrying up for their new plans that might be executed in the year 2018.

It was revealed by NASA sciences Chief Mr. John Grunsfeld that they are positive that the team is able to devise an efficient and cost-effective plan and they won’t have to miss the opportunity by the year 2018. This is going to be a collaboration project that has to be executed with other partners.

The reason 2018 has been chosen is because this is the time Mars is going to be really close to the earth and the chances of reaching the red planet also increase. Scientists have been trying all over the world since a long time to track the way to get to Mars. There have been many efforts of the same sort made in the past as well, but this was supposed to be the one big chance for NASA. They have definitely felt bad about the cuts made by the government but haven’t given hope and are still trying to find a way to get to their target.

“We're trying to identify a way to (explore Mars) in these very difficult fiscal times”, said NASA Administrator Charles Bolden.

FrenchTribune Specials

FDA places partial hold on AstraZeneca’s Ph-III PD-L1 candidate

Pharmaceuticals giant AstraZeneca suffered a major setback on Thursday when the U.S. Food & Drug Administration (FDA) placed a partial hold on enrolment of patients for its final-stage trials of cancer immunotherapy.

The experimental drug called durvalumab is used as monotherapy as well as in combination with tremelimumab to...

Most Popular

Open Medicare enrollment period offers opportunity to choose a new plan

Eligible Medicare enrollees have once again got the...

Emergency room use by Oregon Medicaid patients remains high

Visits to emergency rooms for primary care in Oregon...

Samsung might tap LG Chem as new battery supplier for Galaxy S8

According to The Korean Herald, Samsung is apparently in...


Can Greece Come out of Economic Problems: